AI Article Synopsis
- - A 9-year-old boy diagnosed with linear immunoglobulin A bullous disease experienced severe symptoms and couldn't continue treatment with dapsone due to elevated liver enzymes.
- - His underlying condition included fatty liver, which contributed to the intolerance of the medication.
- - Remarkable recovery occurred with the use of intravenous immunoglobulins alone, leading to rapid symptom relief and lasting remission after treatment ended.
Article Abstract
We report a case of linear immunoglobulin A bullous disease in a 9-year-old boy who presented with rapidly progressive severe disease and could not tolerate dapsone because of high liver enzymes within a week after a low dose of dapsone in association with an underlying fatty liver. He showed remarkable improvement with intravenous immunoglobulins used as monotherapy, with a rapid clearance and a sustained remission after stopping the treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1525-1470.2011.01475.x | DOI Listing |
Publication Analysis
Top Keywords
linear immunoglobulin
8
immunoglobulin bullous
8
bullous disease
8
disease childhood
4
childhood responsive
4
responsive intravenous
4
intravenous immunoglobulin
4
immunoglobulin monotherapy
4
monotherapy report
4
report case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!